Filing Details
- Accession Number:
- 0001127855-10-000208
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-02 13:00:00
- Reporting Period:
- 2010-05-28
- Filing Date:
- 2010-06-02
- Accepted Time:
- 2010-06-02 17:44:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1123695 | Imarx Therapeutics Inc | IMRX | Pharmaceutical Preparations (2834) | 860974730 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1489778 | James Donald Scotti | 11519 Albers Street North Hollywood CA 91601-2610 | President | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-05-28 | 25,542,784 | $0.01 | 27,850,247 | No | 4 | P | Indirect | Red Cat Productions |
$200,000 Promissory Note | Disposition | 2010-05-28 | 0 | $0.00 | 0 | No | 4 | S | Indirect | Red Cat Productions |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | Red Cat Productions |
No | 4 | S | Indirect | Red Cat Productions |
Footnotes
- Red Cat Productions, Inc., a corporation owned 100% by the reporting person, gave notice of its election to convert a Promissory Note principal amount of $200,000 payable to Red Cat by the Company into shares of the Company's common stock. Pursuant to the terms of the note, the conversion price was calculated as the average three trading prices of the shares of Company common stock on the three trading days preceding the date of conversion.
- The shares will be issued to Red Cat Productions, Inc. following an amendment to the Company's certificate of incorporation resulting in an increase in the authorized number of shares of common stock of the Company. The amendment is expected to be approved by the Company's shareholders in July 2010.